Extended Health Checkup
Our broadest panel: CBC, thyroid, vitamins, lipids, liver, kidney, and HbA1c.
Lp(a), in full lipoprotein(a), is an LDL lipoprotein according to the Dutch guideline on inherited dyslipidaemia, a lipid particle that carries cholesterol, with a protein called apolipoprotein(a) coupled to it. According to the European Atherosclerosis Society (EAS), Lp(a), like LDL, is a particle with apoB, but far fewer of them circulate.
A high Lp(a) is causally associated with cardiovascular disease and with narrowing of the aortic valve according to the EAS, and the value is largely inherited. Only a blood test shows how much Lp(a) there is.
Unilabs measures Lp(a) in nanomoles per litre, uses < 60 nmol/l as the reference value, without distinguishing by sex, and calls 75 to 125 nmol/l a grey zone for cardiovascular disease.
Doctor's Assessment Included
Lp(a) is a fat particle whose level is largely inherited. Laboratories report it in nmol/l or mg/l, so a result can only be compared with the limit of the laboratory that measured it.
| Result | Value (g/l) |
|---|---|
| Normal | < 0,3 |
| Borderline | 0,3–0,5 |
| Elevated | ≥ 0,5 |
Lp(a) is largely inherited and stays almost constant throughout life. The risk rises gradually with the value; the EAS stresses that there is no biological threshold. The NHG guideline CVRM uses > 50 mg/dl (0.50 g/l, 80th percentile) as the cut-off and advises against screening the general population. Some laboratories apply a stricter upper limit (0.3 g/l), which matches the lower end of the EAS grey zone.
Source: Nederlands Huisartsen Genootschap Reference population: Adults (NHG guideline CVRM; EAS 2022)
Source: European Atherosclerosis Society Reference population: Adults (NHG guideline CVRM; EAS 2022)
Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.
The upper limit runs from 60 nmol/l at Unilabs to 75 nmol/l at Star-shl.
| Laboratory | Group | Reference value (nmol/l) | Relative scale |
|---|---|---|---|
| Star-shl | · Everyone · a limit, not a range | < 75 nmol/l |
75
|
| Unilabs | · Everyone · a limit, not a range | < 60 nmol/l |
60
|
| Unilabs | · Everyone · grey zone for cardiovascular disease | 75–125 nmol/l |
75 125
|
| Unilabs | · Everyone · a limit, not a range · raised risk of cardiovascular disease | > 125 nmol/l |
125
|
| Certe | · Everyone · 18 years and older · a limit, not a range | < 500 mg/L mg/L | |
| Certe | · Everyone · grey zone | 300–500 mg/L mg/L | |
| Certe | · Everyone · a limit, not a range · high risk | > 500 mg/L mg/L | |
| Diagnostiek voor U | · Everyone · a limit, not a range | < 75 nmol/L |
75
|
Source: Star-shl
Source: Unilabs
Source: Certe
Source: Diagnostiek voor U
Each value as the laboratory itself publishes it, retrieved in 2026.
An Lp(a) measurement gives the concentration of lipoprotein(a) in the serum, at Unilabs in nanomoles per litre. Unilabs writes that the Lp(a) concentration is mostly genetically determined and inversely related to the number of repeats of a protein domain in apo(a): fewer repeats, more Lp(a).
The risk of cardiovascular disease rises gradually with the Lp(a) value according to the EAS, also at values below the usual limits. The Dutch guideline on inherited dyslipidaemia considers that risk raised with an Lp(a) above the 80th percentile, 50 mg/dl.
The 2022 EAS consensus advises measuring Lp(a) at least once in every adult; the Dutch guideline on inherited dyslipidaemia sees no justification for screening the general population. The Dutch guideline names a family history of cardiovascular disease or of raised Lp(a) as a situation in which a measurement can be considered.
A low Lp(a), below 60 nmol/l at Unilabs, falls within the reference value. Hormone replacement therapy after menopause lowers Lp(a) by about 25% according to the EAS.
According to the EAS, a high Lp(a) makes narrowing of the aortic valve and cardiovascular disease more likely. During pregnancy, Lp(a) rises to double according to the EAS.
Reduced liver function
Lp(a) is made in the liver, so a poorly working liver can lower the level.
Overactive thyroid
An overactive thyroid can lower Lp(a); after treatment the level rises by 20 to 25 percent.
Hormone therapy after menopause
Hormone replacement therapy after menopause lowers Lp(a) by about 25 percent.
Severe acute illness
In life-threatening conditions such as sepsis or severe burns, Lp(a) is lower.
Inherited level
The Lp(a) level is thought to be mainly set by the genes and to barely change from adulthood.
Kidney disease
Reduced kidney function can raise Lp(a), and in nephrotic syndrome the level is 3 to 5 times higher.
Pregnancy
Lp(a) can double during pregnancy.
Underactive thyroid
An underactive thyroid can raise Lp(a); treatment lowers it by 5 to 20 percent.
With a high Lp(a), the EAS reads the result within the total risk of cardiovascular disease. According to the Dutch guideline on inherited dyslipidaemia, lowering Lp(a) with hormone replacement therapy or with nicotinic acid did not lead to less cardiovascular disease in studies.
The EAS consensus is not consistent about Lp(a) after menopause: its text says that in women the value tends to increase at menopause, while its table of non-genetic influences lists no or minimal effect for menopause.
Yes, according to the EAS Lp(a) is generally about 5 to 10% higher in women than in men, in both Black and White people. The EAS describes the Lp(a) level of men as relatively constant.
Yes, an underactive thyroid raises Lp(a) according to the EAS, and treatment lowers the value by 5 to 20%. An overactive thyroid lowers Lp(a), and after treatment with thyroid-suppressing medicine or radioactive iodine the value rises by 20 to 25%.
Add us as a preferred source. Google will then show our articles more often in your search results and in AI overviews. You can turn this off again at any time.
That did not work. Please try again.
These panels measure values from the same category as this marker.
Our broadest panel: CBC, thyroid, vitamins, lipids, liver, kidney, and HbA1c.
Key health markers: CBC, lipids, and Vitamin D.
LDL, HDL, and Triglycerides: your cardiovascular risk markers.
Medical reviewer
Dr. Naimi oversees the medical standards behind our content and assessments.
Medical policyDoctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
Lipoprotein(a)
€36,-
We use cookies to analyze site usage and measure ad effectiveness. Privacy Policy